Mirai Bio Partners with Thermo Fisher to Boost Genetic Medicine Development
Deal News | May 20, 2025 | Flagship Pioneering Inc
Mirai Bio, an innovative company founded by Flagship Pioneering, has announced a strategic partnership with Thermo Fisher Scientific to enhance the development of genetic medicines. The collaboration will combine Thermo Fisher's extensive capabilities in development and commercial manufacturing with Mirai's advanced machine intelligence platform for optimized delivery and development of nucleic acid therapeutics. This partnership is expected to expedite program development and commercialization globally, leveraging Thermo Fisher's state-of-the-art RNA and Advanced Formulations facility. The collaboration also marks a direct investment in Mirai, indicating a strategic expansion of the existing relationship between Flagship Pioneering and Thermo Fisher. Mirai intends to use this alliance to strengthen its platform and advance the co-creation of targeted, potentially curative programmable medicines.
Sectors
- Biotechnology
- Pharmaceutical Manufacturing
Geography
- United States – Mirai Bio is based in Cambridge, Massachusetts, and Thermo Fisher Scientific is headquartered in the U.S., making it a central geography for the partnership.
Industry
- Biotechnology – The article discusses genetic medicines, which are a central focus in the field of biotechnology.
- Pharmaceutical Manufacturing – Thermo Fisher's role in providing pharmaceutical manufacturing services is highlighted in the collaboration.
Financials
- Not specified – The article mentions a strategic investment but does not disclose specific financial terms.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Mirai Bio | Target | Company | Mirai Bio is an innovative company co-creating optimized genetic medicines and was founded by Flagship Pioneering. |
| Flagship Pioneering | PE Firm | Company | The private equity firm that founded Mirai Bio to innovate in the field of genetic medicines. |
| Thermo Fisher Scientific | Collaborative Partner | Company | A world leader in serving science, providing developmental and manufacturing services for the partnership. |
| Travis Wilson | Executive Chairman of Mirai and Growth Partner, Flagship Pioneering | Person | Provides remarks on the partnership and its aspiration to advance genetic medicine. |
| Vincent Hingot | President, Drug Substance, Pharma Services, at Thermo Fisher | Person | Comments on Thermo Fisher's role in the partnership with Mirai Bio. |
| Justine Levin-Allerhand | Executive Partner, Origination and Corporate Development at Flagship | Person | Discusses the strategic expansion of the relationship with Thermo Fisher. |